Ionis Expands Surf Away+ for 10th Anniversary
Ionis expands Surf Away+ event, marking 10 years of creating unique adaptive experiences for people with neurological diseases Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today celebrated 10 years of Surf Away+, an…
QIAGEN Achieves CE-IVDR Certification for Entire QIAstat-Dx Diagnostic Portfolio in Europe
QIAGEN Secures CE-IVDR Certification for Full QIAstat-Dx Portfolio, Expands Diagnostic Leadership with Enhanced Meningitis/Encephalitis Panel QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) has announced a significant regulatory milestone: the…
AGC Biologics Seattle Marks Milestone Year with Approvals and ISO Certification
AGC Biologics Seattle Facility Celebrates Milestone Year with Regulatory Approvals, Quality Achievements, and Leadership Expansion AGC Biologics, a leading global contract development and manufacturing organization (CDMO), has announced that its…
Modeyso™ Added to NCCN Guidelines for H3 K27M-Mutant Diffuse Glioma
Modeyso™ (Dordaviprone) Gains Inclusion in NCCN Clinical Practice Guidelines, Marking a Milestone in the Treatment of H3 K27M-Mutant Diffuse Glioma Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced a pivotal development for…
ScaleReady Launches G-Rex® Grant Program to Advance Cell and Gene Therapy Manufacturing in California
ScaleReady Awards G-Rex® Grants to Advance Cell and Gene Therapy Manufacturing Across California ScaleReady, a joint venture formed by Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH), and CellReady, announced a…
Royalty Pharma Publishes Deloitte Analysis on the Evolving Biopharma Royalty Market
Royalty Pharma and Deloitte Release Landmark Study on the Role of Royalties in Funding Biopharma Innovation Royalty Pharma plc (Nasdaq: RPRX), the world’s largest acquirer of biopharmaceutical royalties and a…
Novartis Acquires Tourmaline Bio to Boost ASCVD Pipeline with Pacibekitug
Novartis to Acquire Tourmaline Bio, Advancing Cardiovascular Pipeline with Pacibekitug for ASCVD Novartis today revealed a major step forward in its cardiovascular disease (CVD) strategy with the announcement that it…
BOTOX® Cosmetic Launches “The One & Only” Campaign
BOTOX® Cosmetic Unveils “The One & Only” Campaign: A Celebration of Authenticity, Self-Expression, and Patient Stories A New Chapter for an Iconic Brand BOTOX® Cosmetic (onabotulinumtoxinA), one of the most…
Avanzanite Bioscience Appoints Dr. Mark Bechter as Senior Vice President of Medical Affairs
Avanzanite Bioscience Strengthens Leadership with Appointment of Dr. Mark Bechter as Senior Vice President of Medical Affairs Avanzanite Bioscience B.V., a rapidly expanding European specialty pharmaceutical company dedicated to improving…
Alnylam Prices Upsized $575 Million Convertible Senior Notes Offering
Alnylam Pharmaceuticals Prices Upsized $575 Million Convertible Senior Notes Offering, Strengthening Balance Sheet and Advancing Growth Strategy Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a recognized global leader in RNA interference (RNAi)…
Agenus’ BOT/BAL Wins AAC Reimbursement in France for Refractory MSS mCRC
France Grants Reimbursed Compassionate Access for Agenus’ Botensilimab plus Balstilimab in Refractory MSS Metastatic Colorectal Cancer In a significant development for patients with advanced colorectal cancer, Agenus Inc. (Nasdaq: AGEN),…
Cascade Bio Raises $6M to Accelerate Growth of Next-Gen Biocatalysts
Cascade Bio Secures $6 Million to Advance Biocatalyst Innovation and Transform Biomanufacturing In a world grappling with climate change, supply chain disruptions, and the growing demand for sustainable manufacturing, biotechnology…